0001104659-19-059505.txt : 20191104 0001104659-19-059505.hdr.sgml : 20191104 20191104161550 ACCESSION NUMBER: 0001104659-19-059505 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191031 FILED AS OF DATE: 20191104 DATE AS OF CHANGE: 20191104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Love Colin CENTRAL INDEX KEY: 0001376493 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 191189987 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 18 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 10801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: DE ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: DE ZIP: 01801 4 1 a4.xml 4 X0306 4 2019-10-31 0 0001737953 Replimune Group, Inc. REPL 0001376493 Love Colin C/O REPLIMUNE GROUP, INC. 18 COMMERCE WAY WOBURN MA 01801 0 1 0 0 Chief Operating Officer Common Stock 2019-10-31 4 S 0 11250 17.00 D 1096524 D The sale reported on this Form 4 was made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. Following the sale reported on this Form 4, the reporting person continues to beneficially own 1,096,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 328,103 shares of the Issuer's common stock, 115,169 of which are exercisable as of the date hereof. /s/ Robert Coffin, attorney-in-fact 2019-11-04